Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sedation in pediatric imaging using intranasal midazolam

H T Harcke1, L E Grissom, M A Meister

  • 1Department of Medical Imaging, Alfred I. duPont Institute, Wilmington, DE 19899, USA.

Pediatric Radiology
|January 1, 1995
PubMed
Summary

Intranasal midazolam provides a safe and effective sedation option for pediatric medical imaging. This method is convenient for short procedures, especially in younger children, when administered at 0.2 mg/kg.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone mineral density in MPS IV A (Morquio syndrome type A).

Molecular genetics and metabolism·2015
Same author

Common and expected postmortem CT observations involving the brain: mimics of antemortem pathology.

AJNR. American journal of neuroradiology·2012
Same author

Imaging in the surgical management of developmental dislocation of the hip.

Clinical orthopaedics and related research·2008
Same author

Experimental epiphysiodesis: magnetic resonance imaging evaluation with histopathologic correlation.

International orthopaedics·2002
Same author

Infant shoulder sonography: technique, anatomy, and pathology.

Pediatric radiology·2001
Same author

Ultrasonographic evaluation of hip morphology in osteochondrodysplasias.

Journal of pediatric orthopedics·2000

Area of Science:

  • Pediatric Sedation
  • Medical Imaging
  • Pharmacology

Background:

  • Sedation is crucial for pediatric medical imaging to ensure patient cooperation and image quality.
  • Traditional sedative agents like intravenous and oral formulations present challenges in administration and onset for children.
  • Intranasal midazolam is explored as a potentially superior alternative due to ease of administration and rapid effect.

Purpose of the Study:

  • To evaluate the safety and efficacy of intranasal midazolam as a sedative agent for pediatric medical imaging.
  • To determine optimal dosing and application scenarios for intranasal midazolam in pediatric patients.

Main Methods:

  • Retrospective review of cases involving intranasal midazolam administration for pediatric medical imaging.
  • Dose administered: 0.2 mg/kg for younger children requiring short-procedure sedation.

Related Experiment Videos

  • Evaluation of safety and effectiveness based on clinical observation and procedure success.

    • Main Results:

    • Intranasal midazolam demonstrated a safe and effective profile for pediatric sedation in medical imaging.
    • Convenient administration and rapid onset were noted as key advantages over other routes.
    • The agent proved effective for short procedures, often as an adjunct to other sedatives.

    Conclusions:

    • Intranasal midazolam (0.2 mg/kg) is a recommended sedative for pediatric medical imaging, particularly for younger children and short procedures.
    • Adherence to American Academy of Pediatrics sedation guidelines is advised for optimal patient safety.
    • Further research may explore its role in conjunction with other sedative agents for extended procedures.